Skip to main content

Unstable Heart Failure

  • Chapter
Atlas of HEART FAILURE
  • 171 Accesses

Abstract

Unstable heart failure represents the clinical state of progressively worsening or decompensated heart failure, which, if not improved within a reasonable time (usually minutes to hours), often evolves into markedly symptomatic heart failure, cardiovascular collapse, and shock or death. The clinical settings include, among others, the patient who arrives in the emergency room in acute pulmonary edema, the patient with postinfarction cardiogenic shock, the patient who cannot be weaned from cardiopulmonary bypass after cardiac surgery, or the chronic heart failure patient who is experiencing a rather abrupt worsening of symptoms. Most patients with unstable heart failure must be approached with a certain sense of urgency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldberger JJ, Peled HB, Stroh JA, et al.: Prognostic factors in acute pulmonary edema. Arch Intern Med 1986,146:489–493.

    Article  PubMed  CAS  Google Scholar 

  2. Forrester JS, Diamond G, Chatterjee K, et al.: Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976,295:1356–1362,1404–1413.

    Google Scholar 

  3. Goldberg RJ, Yarzebski J, Lessard D, Gore JM: A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case fatality rates of acute myocardial infarction: a community-wide perspective. J Ant Coll Cardiol 1999, 33: 1533–1539.

    Article  CAS  Google Scholar 

  4. Guidry UC, Evans JC, Larson MG, et al.: Temporal trends in event rates after Q wave myocardial infarction: the Framingham Heart Study. Circulation 1999, 100:2054–2059.

    Article  PubMed  CAS  Google Scholar 

  5. Sanborn TA, Sleeper LA, Webb JG, et al.: Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction. J Am Coll Cordial 2003, 42:1373–1379.

    Article  Google Scholar 

  6. Heart Failure Guidelines Committee of the American College of Cardiology/American Heart Association: Guidelines for the evaluation and management of heart failure. J Am Call Cardiol 1995, 26: 1376–1398. (revised: 2001, 38:2101–2113).

    Google Scholar 

  7. HFSA Guidelines Committee: HFSA guidelines for the management of patients with heart failure caused by left ventricular systolic dysfunction. J Cardiac Failure 1999, 5: 357–382.

    Article  Google Scholar 

  8. Franciosa JA, Guiha NH, Limas CL, et al.: Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1972,1:650–654.

    Article  PubMed  CAS  Google Scholar 

  9. Leier CV, Bambach D, Thompson MJ, et al.: Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin, and nitroprusside in patients with congestive heart failure. Am J Cardiol 1981, 48:1115–1123.

    Article  PubMed  CAS  Google Scholar 

  10. Mills RM, LeJeuntel TH, Horton DP, et al.: Sustained hemodynamic effects of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. J Am Call Cardiol 1999, 34:155–162.

    Article  CAS  Google Scholar 

  11. Colucci WS, Elkayan U, Horton DP, et al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated heart failure. N Engl J Med 2000, 343:246–253.

    Article  PubMed  CAS  Google Scholar 

  12. Leier CV, Binkley PF: Parenteral inotropic support for advanced heart failure. Prag Cardiovasc Dis 1998, 41: 207–214.

    Article  CAS  Google Scholar 

  13. Loeb HS, Winslow EBJ, Rahimtoola SH, et al.: Acute hemodynamic effects of dopamine in patients with shock. Circulation 1971, 44:163–173.

    Article  PubMed  CAS  Google Scholar 

  14. Holzer J, Karliner JS, O’Rourke RA, et al.: Effectiveness of dopamine in patients with cardiogenic shock. Am J Cordial 1973, 32:79–84.

    Article  CAS  Google Scholar 

  15. Leier CV, Webel J, Bush CA: The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 1977, 56: 468–472.

    Article  PubMed  CAS  Google Scholar 

  16. Leier CV, Heban PT, Huss P, et al.: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with heart failure. Circulation 1978, 58:466–475.

    Article  PubMed  CAS  Google Scholar 

  17. Francis GS, Sharma B, Hodges M: Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 1982, 103: 995–1000.

    Article  PubMed  CAS  Google Scholar 

  18. Jaski B, Fifer MA, Wright RF, et al.: Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest 1985, 75:643–649.

    Article  PubMed  CAS  Google Scholar 

  19. Sander CA, Buckley MJ, Leinbach RC, et al.: Mechanical circulatory assistance: current status and experience with combining circulatory assistance, emergency coronary angiography, and acute myocardial revascularization. Circulation 1972, 45:1291–1313.

    Google Scholar 

  20. Bardet J, Masquet C, Kahn J-C, et al.: Clinical and hemodynamic results of intra-aortic balloon counterpulsation and surgery for cardiogenic shock. Am Heart J 1977, 93:280–288.

    Article  PubMed  CAS  Google Scholar 

  21. Johnson SA, Scanlon PJ, Loeb HS, et al.: Treatment of cardiogenic shock in myocardial infarction by intra-aortic balloon counter-pulsation and surgery. Am J Med 1977, 62:687–692.

    Article  PubMed  CAS  Google Scholar 

  22. Kovack PJ, Rasak MA, Bates ER, et al.: Thrombolysis plus aortic counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980, 61:1105–1112.

    Google Scholar 

  23. Torchiana DF, Hirsch G, Buckley MJ, et al.: Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surer 1997, 113:758.

    Article  Google Scholar 

  24. Califf RM: Ten years of benefit from a one-hour intervention. Circulation 1998, 98: 2649–2651.

    Article  PubMed  CAS  Google Scholar 

  25. Rothbaum DA, Linnemeier TJ, Landin RJ, et al.: Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Ant Coll Cardiol 1987, 10:264–272.

    Article  CAS  Google Scholar 

  26. Lee L, Bates ER, Pitt B, et al.: Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988, 78:1345–1351.

    Article  PubMed  CAS  Google Scholar 

  27. Ellis SG, O’Neill WW, Bates ER, et al_: Implications of patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cordial 1989, 13: 1251–1259.

    Article  CAS  Google Scholar 

  28. Lee L, Erbel R, Brown TM, et al.: Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Call Cardiol 1991, 17:599–603.

    Article  CAS  Google Scholar 

  29. Hochman JS, Boland J, Sleeper LA, et al.: Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Circulation 1995, 91:873–881.

    Article  PubMed  CAS  Google Scholar 

  30. Lamas GA, Glaker GA, Mitchell G, et al.: Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995, 92:1101–1109.

    Article  PubMed  CAS  Google Scholar 

  31. Holmes DR Jr, Bates ER, Kleiman NS, et al.: Contemporary reperfusion therapy for cardiogenic shock: the Gusto-1 trial experience. J Am Coll Cordial 1995, 26:668–674.

    Article  Google Scholar 

  32. Berger PB, Holmes DR, Stebbins AL, et al. for the Gusto-1 Investigators: Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Gusto-1 trial. Circulation 1997, 96: 122–127.

    Article  PubMed  CAS  Google Scholar 

  33. Dangas G, Stone GW: Primary mechanical reperfusion in acute myocardial infarction: the United States experience. Semin Intervent Cardiol 1999, 4: 21–33.

    CAS  Google Scholar 

  34. Hochman JS, Sleeper LA, Webb JG, et al.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock: should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999, 341:625–634.

    Article  PubMed  CAS  Google Scholar 

  35. Abraham WT, Fisher WG, Smith AL, it al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346: 1845–1853.

    Article  PubMed  Google Scholar 

  36. Young JB, Abraham WT, Smith AL, et al.: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced heart failure. JAMA 2003, 289:2685–2694.

    Article  PubMed  Google Scholar 

  37. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435–1443.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media New York

About this chapter

Cite this chapter

Leier, C.V., Orsinelli, D.A. (2005). Unstable Heart Failure. In: Colucci, W.S. (eds) Atlas of HEART FAILURE. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4558-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4558-0_9

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-4560-3

  • Online ISBN: 978-1-4757-4558-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics